|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 217/02 | |
| C07D 217/24 | |||
| C07D 401/12 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07C 237/00 | |||
| A61P 27/00 | |||
| A61K 31/33 | |||
| A61K 31/47 |
| (11) | Number of the document | 3053913 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15002893.4 |
| Date of filing the European patent application | 2010-01-27 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 174672 P | 2009-05-01 | US |
| (72) |
DELONG, Mitchell A, US
STURDIVANT, Jill Marie, US
ROYALTY, Susan M., US
|
| (73) |
AERIE PHARMACEUTICALS, INC.,
7020 Kit Creek Road, Suite 270, P.O. Box 12320, Research Triangle Park, NC 27709,
US
|
| (54) | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |
| DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |